UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome – TechCrunch
There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from anxiety to OCD or, in rare cases, seizures. But a new clinical trial is soon to be underway at a U.K. startup. On Wednesday, drug […]
Source: techcrunch.com